tetano
Editor, Senior Moderator
Allergy
. 2020 Jul 27.
doi: 10.1111/all.14516. Online ahead of print.
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey
A Matucci[SUP] 1 [/SUP], M Caminati[SUP] 2 [/SUP], V Vivarelli[SUP] 1 [/SUP], A Vianello[SUP] 3 [/SUP], C Micheletto[SUP] 4 [/SUP], F Menzella[SUP] 5 [/SUP], E Crisafulli[SUP] 6 [/SUP], G Passalacqua[SUP] 7 [/SUP], D Bagnasco[SUP] 7 [/SUP], C Lombardi[SUP] 8 [/SUP], P Parronchi[SUP] 9 [/SUP], M A Crivellaro[SUP] 10 [/SUP], F Chieco-Bianchi[SUP] 11 [/SUP], M R Marchi[SUP] 12 [/SUP], G Guarnieri[SUP] 11 [/SUP], L Cosmi[SUP] 9 [/SUP], O Rossi[SUP] 1 [/SUP], F Almerigogna[SUP] 1 [/SUP], G Senna[SUP] 2 [/SUP], A Vultaggio[SUP] 1 [/SUP]
Affiliations
Abstract
Several reports describe an higher risk for viral infections in patients with asthma.[SUP]1,2[/SUP] Novel coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that shows a predilection to infect the lower and upper airway tract, thus creating an higher clinical issue in asthmatic patients.[SUP]3[/SUP].
This article is protected by copyright. All rights reserved.
. 2020 Jul 27.
doi: 10.1111/all.14516. Online ahead of print.
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey
A Matucci[SUP] 1 [/SUP], M Caminati[SUP] 2 [/SUP], V Vivarelli[SUP] 1 [/SUP], A Vianello[SUP] 3 [/SUP], C Micheletto[SUP] 4 [/SUP], F Menzella[SUP] 5 [/SUP], E Crisafulli[SUP] 6 [/SUP], G Passalacqua[SUP] 7 [/SUP], D Bagnasco[SUP] 7 [/SUP], C Lombardi[SUP] 8 [/SUP], P Parronchi[SUP] 9 [/SUP], M A Crivellaro[SUP] 10 [/SUP], F Chieco-Bianchi[SUP] 11 [/SUP], M R Marchi[SUP] 12 [/SUP], G Guarnieri[SUP] 11 [/SUP], L Cosmi[SUP] 9 [/SUP], O Rossi[SUP] 1 [/SUP], F Almerigogna[SUP] 1 [/SUP], G Senna[SUP] 2 [/SUP], A Vultaggio[SUP] 1 [/SUP]
Affiliations
- PMID: 32716580
- DOI: 10.1111/all.14516
Abstract
Several reports describe an higher risk for viral infections in patients with asthma.[SUP]1,2[/SUP] Novel coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that shows a predilection to infect the lower and upper airway tract, thus creating an higher clinical issue in asthmatic patients.[SUP]3[/SUP].
This article is protected by copyright. All rights reserved.